Phillip Phan

Phillip Phan, PhD

Alonzo and Virginia Decker Professor of Strategy and Entrepreneurship
Academic AreaManagement & Organization
Academic AreaInnovation & Entrepreneurship
Academic AreaHealth
Areas of InterestTechnological Entrepreneurship, National Innovation Systems and Technology Policy, Corporate Governance of Family Enterprises, Patient Safety and Quality, Transitions of Care

Phillip H. Phan, Ph.D., is Alonzo and Virginia Decker Professor in the Johns Hopkins Carey Business School with a joint appointment as Professor in the Department of Medicine at Johns Hopkins Medicine. He is Robert Bosch Policy Fellow at the American Academy in Berlin. His academic and professional work focuses on technology innovation and entrepreneurship in healthcare, especially in the domains of patient safety and quality. He has published more than 200 peer reviewed research papers, abstracts, and conference proceedings and is author or editor of 12 scholarly books. He is Editor-in-Chief of the Academy of Management Perspectives, Academic Editor of Medicine® (health services research section), and Associate Editor of the Journal of Technology Transfer. He currently serves on review panels for the National Academies of Sciences, Hong Kong University Grants Council, and the National Science Foundation. He is co-founder of P4 Microbiome Inc., focused on antimicrobial therapies for the GI tract, and Pistevo LLC, focused on AI-driven phenotyping of cancer patients from electronic medical records.

How to Connect Increased Pharma R&D with New Medicines

Education

  • Ph. D, University of Washington - Seattle
  • BBA, Hospitality Management School of Travel Industry Management, University of Hawaii - Manoa

Research

    Selected publications

    • J Samuels, C Holingue, PS Nestadt, OJ Bienvenu, P Phan, G Nestadt (2021) Contamination-related behaviors, obsessions, and compulsions during the COVID-19 pandemic in a United States population sample, Journal of Psychiatric Research 138, 155-162
    • CX Wu, E Suresh, FWL Phng, KP Tai, J Pakdeethai, JLA D’Souza, P Tan, W Shin, P Phan, KSM Lew, GSW Tan, GYH Chua, CH Hwang (2021) Effect of a Real-Time Risk Score on 30-day Readmission Reduction in Singapore, Applied Clinical Informatics 12, 372-382
    • M Macis, M Grunauer, E Gutierrez, R Izurieta, P Phan, MR Ortiz, C Rosas, E Teran (2021) Using Incentives and Nudging to Improve Non-Targeted HIV Testing in Ecuador: A Randomized Trial, AIDS and Behavior, 1-9
    • K Marr, P Phan (2021) The valorization of non-patent intellectual property in academic medical centers, The Journal of Technology Transfer 45 (6), 1823-1841
    • SH Lee, C Terndrup, PH Phan, SE Zaeh, K Atsina, N Minkove, A Billioux, S Chatterjee, I Montague, B Clark, A Hughes, SV Desai (2017) A Randomized Cohort Controlled Trial to Compare Intern Sign-Out Training Interventions, Journal of hospital medicine 12 (12), 979-983
    • JL Walls, P Berrone, P Phan (2012) Corporate governance and environmental performance: Is there really a link?, Strategic Management Journal 33 (8), 885-913
    • CWL Hill, P Phan (1991) CEO tenure as a determinant of CEO pay, Academy of Management Journal 34 (3), 707-717

    Working papers

    • M Lahiri, PPM Cheung, P Dhanasekaran, SR Wong, A Yap, DSH Tan, SH Chong, CH Tan, A Santosa, P Phan (2021) A Randomized Controlled Evaluation of a Multidisciplinary Rheumatoid Arthritis Care Model, Journal of General Internal Medicine (under review)
    • M Reina Ortiz, M Grunauer, R Izurieta, M Macis, P Phan, E Teran (2021) Financial incentives, not behavioral nudges, optimize HIV testing among pregnant women in a highly Afro-descendant, high-HIV burden urban population, American Journal of Tropical Medicine and Hygiene (under review)
    • RH Rousseau, P Phan, P Berrone (2021) Entrepreneurship, Institutional Fields, and Poverty Alleviation, Journal of Business Venturing (in review)

    Teaching

    Current

    • Entrepreneurial Ventures
    • Design Lab
    • Commercializing Discoveries
    • International Social Innovation and Value Creation

    Previous

    • Research and Policy Seminars in Health
    • Social Innovation and Business Sustainability
    • Corporate Strategy
    • Innovation for Humanity
    • Discovery to Market
    • Networked Organizations

    Honors and distinctions

    • Haniel-Stiftungsgastprofessur, Wirtschaftswissenschaftliche Fakultät, Humbolt-Universität zu Berlin (2004)
    • Associate Editor, Journal of Business Venturing (2001-2015)
    • Associate Editor, Journal of Financial Stability (2003-2019)
    • Robert Bosch Foundation Public Policy Fellow, The American Academy in Berlin (2007)
    • Tommie Goh Distinguished Visiting Professor, Singapore Management University (2008)
    • Associate Editor, Journal of Technology Transfer (2011-)
    • Associate Editor, Journal of Family Business Strategy (2014-2020)
    • Editor-in-Chief, Academy of Management Perspectives (2014-)
    • Academic Editor, Medicine® (health services research) (2014-)
    • STaRs Visiting Professor, University of Bergamo, Italy (2019)

    Impact and engagement 

    Business

    Co-founder of: 

    • P4 Microbiome Inc., developer of antimicrobials for the gastrointestinal tract
    • Pistevo LLC, developer of AI solutions to improve medical billing accuracy
    • FKP Consulting LLC, consultancy devoted to vascular and interventional radiology.

    Community

    • Mentor, A-Level Capital
    • Editor, eix.org (Entrepreneurship and Innovation Exchange)

    In the media

    Jump to top of page